Great addition to the management team of Tagworks Pharmaceuticals: Ken Mills joining as CEO. Marc Robillard Edwin de Graaf Pieter van der Meer Ariane Daney de Marcillac Arthur Franken Besmire Ahmati Christopher Allen Dirkjan B. Edward Hanlon Geoff Pardo Henry Zubaida Janke Dittmer Joep Muijrers Karthik Bolisetty Marion Pouillard Pommeline Korstanje Richard Wilmot Sonia Hallen Stefan Luzi, PhD Susana Amorim Lopes Tristan Maguet Zosia van Eesteren Jan Willem Bakker Renee van der Ven
Gilde Healthcare
Vermogensbeheer
Specialized healthcare investor in both Healthcare Venture & Growth as well as Healthcare Private Equity, managing €2.5B
Over ons
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. Gilde Healthcare's lower mid-market buy-out fund invests in profitable European healthcare services companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are based in Europe and North America. Since 2001 Gilde Healthcare has raised €2.5 billion for its specialized funds.
- Website
-
http://www.gildehealthcare.com
Externe link voor Gilde Healthcare
- Branche
- Vermogensbeheer
- Bedrijfsgrootte
- 11 - 50 medewerkers
- Hoofdkantoor
- Utrecht
- Type
- Particuliere onderneming
- Opgericht
- 1982
- Specialismen
- Private Equity, Growth Capital, Buy Out, Healthcare, Health Care en Venture Capital
Locaties
-
Primair
Stadsplateau 36
Utrecht, 3521AZ, NL
-
575 Boylston St
Floor 8
Boston, Massachusetts 02116, US
-
Neue Mainzer Straße 74
Frankfurt, Hesse 60311, DE
Medewerkers van Gilde Healthcare
Updates
-
We are excited to announce the combination of two great companies today as Spire Health joins forces with Wellinks, creating the premier virtual cardiopulmonary care offering in the market. A big thank you to the team, investors and others who made Spire’s vision a reality, including Michael Doyle Dimas Jimenez Aashish M. Neema Moraveji Shena Park Mike Falkowitz, MBA, ICP-ACC, CSM, SA, CSPO Joanne Hollenbach Doug Keare Mark Holt Chris Raanes Richard Murray Wayne Wu Kari Severson Snaza Asit Gosar Geoff Pardo Edward Hanlon Richard Wilmot Mark Lang and the many others who contributed so much over the years.
Gilde Healthcare company Spire Health merges with Wellinks to form Industry Leader in Predictive Patient Care for Cardiopulmonary Health - Gilde Healthcare
gildehealthcare.com
-
Congratulations to our Private Equity team for winning the PE/VC Firm Exit Deal of the Year at the ACG - Holland Growth Awards 2024! 🎉 A great achievement that further solidifies our leadership in the Dutch mid-market healthcare sector. #GrowthAwards2024 #PrivateEquity #HealthcareExcellence Jasper van Gorp Boyd Rutten Dirkjan B. Giel Modderman Hugo de Bruin Jan Willem Bakker Jelte Goettsch Joep Heldens Josephine Bogaerts Kasia Lorek Lara Hilgert Martin von Berg Pheline Charlotte Mulitze Pieter van der Meer Rafael Natanek Raphael Arndt Redmar Koene Robert Stein Stephan Wachtveitl Tom Klein Robbenhaar Besmire Ahmati Renee van der Ven Ludo Suykerbuyk Gülbahar Gülten
ACG Holland Growth Awards 2024 - A Big Congratulations to Gilde Healthcare! We're thrilled to announce Gilde Healthcare as the winners of the PE/VC Firm Exit Deal of the Year 2024! 🏆 A huge shout-out to Hugo de Bruin and Josephine Bogaerts for collecting the trophy on behalf of the team. Congratulation also to the advisory parties - Orange Clover and Allen & Overy. A special thanks to Greenberg Traurig Amsterdam for sponsoring this award, with Maarten de Boorder proudly representing. What an incredible achievement for all involved—celebrating success and innovation in the Dutch mid-market sector! #GrowthAwards2024 #ACGHolland #Networking #GildeHealthcare #PrivateEquity #VentureCapital #Mergersandaquisitions #CelebratingExcellence
-
How do financial investors and strategics partner to support venture-backed startups? Please join our colleague Janke Dittmer during the panel discussion at LSI Europe ’24 on Sep 16 in Sintra, Portugal. #LSIEurope2024
-
Gilde Healthcare is delighted to share that its portfolio company Big Health has received FDA clearance for DaylightRx, a digital treatment for generalized anxiety disorder. This is the first FDA cleared digital treatment for GAD and fills a significant gap in care. Big thank you to the incredibly talented team at Big Health that worked to bring Daylight to this critical milestone. Jenna Carl, PhD Colin A. Espie Peter Hames Arun Gupta Anand Shah, MD Yael Berman Janke Dittmer
We’re excited to share more big news.. DaylightRx has received FDA clearance! 🎉 The US Food and Drug Administration has granted clearance for DaylightRx, our digital treatment for generalized anxiety disorder. This milestone comes just weeks after the FDA granted clearance for SleepioRx, our digital treatment for insomnia. There have been limited options for patients seeking non-drug treatments for anxiety for far too long, so we’re thrilled to be able to offer an FDA-cleared digital treatment that is safe and effective with a remission rate of over 70%. Full press release: https://lnkd.in/gPRjmfye Read more about the impact of this latest clearance: https://lnkd.in/gj-em9gf #anxiety #digitaltherapeutics #digitaltreatments
-
Gilde Healthcare is participating in the Tech Tour Growth Health 2024 in Lausanne next week. 💡 Our team is looking forward to connecting with fellow industry experts and pioneers in the healthcare space. Janke Dittmer Ariane Daney de Marcillac #GildeHealthcare #TechTourGrowthHealth #HealthcareInnovation #Lausanne2024 #HealthTech
-
We will be attending LSI Europe 2024, Medtech's premier partnering event September 16th-20th. Looking forward to connecting with industry leaders and exploring new opportunities at #LSIEurope2024 Janke Dittmer See you there!
-
Please join us in congratulating Antony Mattessich on his well-deserved appointment as new CEO of Amphista Therapeutics Limited and wishing him and the entire Amphista team great success as they work to advance life-changing treatments for patients. The future is looking bright! #bettercareatlowercost #therapeutics #proteindegration #TPG Antony Mattessich Louise Modis Martin Pass Giles Brown Stefan Luzi, PhD Arthur Franken Marion Pouillard Zosia van Eesteren Edwin de Graaf Joep Muijrers Pieter van der Meer Sonia Hallen Tristan Maguet Renee van der Ven Besmire Ahmati
We’re excited to announce that Antony Mattessich has been appointed as our new Chief Executive Officer and Board member to steer our next phase of growth. Antony is an experienced CEO with strong capital markets experience and an impressive track record progressing programs from discovery through clinical development and onto commercial success. He will play a critical role in advancing our next generation Targeted Glue™ protein degraders into the clinic and building a robust pipeline. Read the full announcement here: https://lnkd.in/eE7YSVNR #Appointment #Biotech #DrugDiscovery #TPD #TargetedProteinDegradation
-
Gilde Healthcare, the transatlantic specialist investment firm, is pleased to announce the addition of Jan Willem Bakker to its team as Partner & Head of Investor Relations. Jan Willem will focus on Gilde Healthcare’s investor relations activities and contribute to the firm’s capital raising, marketing and communications efforts. With over 20 years of experience in client facing roles in financial services he brings vast experience to benefit existing and new LPs of the Gilde Healthcare platform. "We are pleased to welcome Jan Willem to our Investor Relations and Fundraising team," said Pieter van der Meer, Managing Partner of Gilde Healthcare. "His extensive track record with institutional investors both as an LP and GP, strong industry relationships, and entrepreneurial mindset will help in strengthening our fundraising strategy and investor relationships. He will be instrumental in the foreseen expansion of our fund platform with impactful private equity strategies." Prior to joining Gilde Healthcare, Jan Willem was a partner at Prime Ventures having previously held senior roles at Arcano Partners and Adveq Management AG (now Schroders Capital), during his time at Adveq Jan Willem was a board member of the Dutch Private Equity association (NVP). He began his career in financial services at Kas Bank N.V. "I am very happy to join Gilde Healthcare’s ambitious team and contribute to building out its impactful platform. I look forward to collaborating with existing and prospective investors, investment and finance teams on delivering innovative and successful investment solutions to benefit a range of stakeholders." said Jan Willem.
-
Gilde Healthcare Venture&Growth portfolio company Moximed announced appointment of robert spomer as Senior Vice President of Sales. #sales #medtech #venturecapital #growthcapital #commercialization #knee #osteoarthritis Arthur Franken Pieter van der Meer Edwin de Graaf Janke Dittmer Geoff Pardo
Our sales team is growing! robert spomer has joined #TeamMoximed as SVP of Sales: https://lnkd.in/eGTVUWDw Robert is a #MedTech sales veteran and will play an instrumental role in bringing the MISHA® Knee System to even more markets around the country. Welcome to Moximed, Robert! #Leadership #MoveToMISHA #SportsMedicine #Orthopedics